Science Explorer Interactive view Map
Company · Stevenage · United Kingdom

NeRRe Therapeutics (United Kingdom)

nerretherapeutics.comROR OpenAlex
Research works
12
▲ 162% vs 2013–17
Citations
137
11.6 per fractional work
Top-10% rate
26.9%
record average 16.5%
Open access
46%
world 28%

Not ranked overall: NeRRe Therapeutics (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.32× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 10.00× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 3.01× its world share, 0 worksImmunology and Micro…Neuroscience: 0.62× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 11.47× its world share, 0 worksPharmacology, Toxico…Materials Science: 0.39× its world share, 0 worksMaterials ScienceHealth Professions: 0.26× its world share, 0 worksHealth ProfessionsMedicine: 1.82× its world share, 3 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.5×. Every wedge is a field page.

Which research topics does NeRRe Therapeutics (United Kingdom) publish most on?

By volume in 2022–2025: RNA Research and Splicing, RNA modifications and cancer, Advanced Breast Cancer Therapies and RNA and protein synthesis mechanisms.

RNA Research and Splicing: 1 fractional worksRNA modifications and cancer: 1 fractional worksAdvanced Breast Cancer T…0Advanced Breast Cancer Therapies: 0 fractional worksRNA and protein synthesi…0RNA and protein synthesis mechanisms: 0 fractional worksRespiratory and Cough-Re…0Respiratory and Cough-Related Research: 0 fractional worksDrug Transport and Resis…0Drug Transport and Resistance Mechanisms: 0 fractional worksCRISPR and Genetic Engin…0CRISPR and Genetic Engineering: 0 fractional worksCancer Research and Trea…0Cancer Research and Treatments: 0 fractional worksATP Synthase and ATPases…0ATP Synthase and ATPases Research: 0 fractional worksCancer, Hypoxia, and Met…0Cancer, Hypoxia, and Metabolism: 0 fractional works
Molecular BiologyPulmonary and Respiratory MedicineOncologyBiotechnology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 RNA Research and Splicing Molecular Biology 1 works
  2. 2 RNA modifications and cancer Molecular Biology 1 works
  3. 3 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  4. 4 RNA and protein synthesis mechanisms Molecular Biology 0 works
  5. 5 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 0 works
  6. 6 Drug Transport and Resistance Mechanisms Oncology 0 works
  7. 7 CRISPR and Genetic Engineering Molecular Biology 0 works
  8. 8 Cancer Research and Treatments Biotechnology 0 works
  9. 9 ATP Synthase and ATPases Research Molecular Biology 0 works
  10. 10 Cancer, Hypoxia, and Metabolism Cancer Research 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.6%not open54.4%

World: 28% of research is openly available.

with international co-authors37.3%domestic only62.7%

World: 19% is written across borders.

How has NeRRe Therapeutics (United Kingdom)'s research output changed?

Output in 2018–2022 was 162% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Stevenage

All research institutions in Stevenage

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.